Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03209128 : Cerebral Prophylactic Irradiation With Saving Hippocampus and Amygdala
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Patients over 18 years of age

- Patients with a limited SCLC demonstrated histologically responsive or stable to
radiochemotherapy or patients with a histologically proven extended SCLC responding to

- WHO Performance Index 0-1 and / or Karnovsky Index> 70

- Possibility of long-term monitoring

Exclusion Criteria:

- Concomitant chemotherapy

- Impossibility of performing an MRI or CT without injection

- Presence of cerebral metastases

- History of cerebral irradiation at any time

- Patient suffering from severe collagenosis

- Patient with cognitive disorders with MMSE score <24
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557